Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Chicago
- Study ID
- NCT06395415
- Status
- Recruiting
Conditions
- Cigarette Smoking
- Electronic Nicotine Delivery Systems
- Tobacco Products
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 26 Years
- Healthy Volunteers
- Accepted
Interventions
- EQUIP — BEHAVIORALThe intervention is delivered directly to participants' mobile phones using the Insight® platform, which allows for the implementation of assessments and interventions. Insight has been used in prior mHealth studies and allows for the delivery of tailored content based on parameters, such as intervention stage. The intervention has two stages: 1) Motivational enhancement (weeks 1-2) and 2) Skills and information (weeks 3-6). The first stage of messages will utilize personalized feedback and motivational interviewing prompts, while the second stage will provide health information on ENDS and skills, such as deep breathing. Content is tailored to motivation level (low/medium or high) and dual use status.
- Standard Care — BEHAVIORALThose in the standard advice group will be given offered a sample of NRT, instruction on its use, and will be encouraged to use in conjunction with standard web-based resources on ENDS and cessation over the course of a ten minute walk-through with study staff.
Study Details
Electronic Nicotine Delivery Systems (ENDS) use remains prevalent among young adults, and many have high interest in quitting, yet research on effective intervention is lacking. A mobile health (mHealth) intervention that translates effective smoking cessation materials and pharmacotherapy may be a promising avenue for intervention. The initial phase of the proposed study uses a pilot study to evaluate a novel mHealth intervention for young adult ENDS and dual product (ENDS and combustible cigarette) users.
Key Dates
- Start date
- Apr 25, 2025
- Status verified
- Jan 2026
- Primary completion
- Jul 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 46 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: mobile health (mHealth)Participants in this arm will receive a 6-week mHealth message based intervention through their smartphone. They will also have the option of requesting free nicotine replacement therapy (NRT) throughout the treatment period.
- Active Comparator: Standard careParticipants in this arm will receive a 5-10 minute walk-through of electronic nicotine delivery system (ENDS) and tobacco education and skills based on the most recent evidence. They will also have the options of requesting a sample of NRT.
Primary Outcome Measure
ENDS cessation [ Time Frame: post-treatment (6 weeks) and at 6-week follow-up (week 12). ]
Central Contacts
- Emma Brett, PhD773-834-5341
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Chicago BREATHE Laboratory | Chicago | Illinois | 60637 |
Find similar trials in Chicago, IL
By research site
Related Studies
- Menthol, Inflammation, and Nicotine Transition StudyRecruiting · Rosalind Franklin University of Medicine and Science · North Chicago, Illinois
- The Positively Quit Trial for Smoking CessationRecruiting · University of South Florida · Tampa, Florida
- RTMS Targets Neural Circuits for Smoking CessationRecruiting · Medical University of South Carolina · Charleston, South Carolina
- Beta-Adrenergic Modulation of Drug Cue ReactivityPHASE4 · Recruiting · University of Oklahoma · Tulsa, Oklahoma